Diffuse interstitial fibrosis assessed by cardiac magnetic resonance is associated with dispersion of ventricular repolarization in patients with hypertrophic cardiomyopathy.

Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy. J Am Coll Cardiol (2010) 3.50

Characteristics and possible mechanism of ventricular arrhythmia dependent on the dispersion of action potential durations. Circulation (1983) 2.74

Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy. JACC Cardiovasc Imaging (2013) 2.72

Measurement, interpretation and clinical potential of QT dispersion. J Am Coll Cardiol (2000) 2.33

Morphology and significance of the left ventricular collagen network in young patients with hypertrophic cardiomyopathy and sudden cardiac death. J Am Coll Cardiol (2000) 2.33

Long-term outcome and prognostic determinants in children with hypertrophic cardiomyopathy. J Am Coll Cardiol (1998) 1.92

Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy. Circ Heart Fail (2009) 1.87

T1 Mapping in cardiomyopathy at cardiac MR: comparison with endomyocardial biopsy. Radiology (2012) 1.83

Comparison of QT dispersion in hypertrophic cardiomyopathy between patients with and without ventricular arrhythmias and sudden death. Am J Cardiol (1993) 1.80

Myocardial fibrosis in hypertrophic cardiomyopathy: accurate reflection of histopathological findings by CMR. JACC Cardiovasc Imaging (2013) 1.69

Hypertrophic cardiomyopathy: histopathological features of sudden death in cardiac troponin T disease. Circulation (2001) 1.64

QT dispersion in essential hypertension. QJM (1995) 1.57

Cardiac magnetic resonance detection of myocardial scarring in hypertrophic cardiomyopathy: correlation with histopathology and prevalence of ventricular tachycardia. J Am Coll Cardiol (2009) 1.44

QT interval in cardiac amyloidosis. Clin Cardiol (1996) 1.41

T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy. Circ Cardiovasc Imaging (2013) 1.35

Dispersion of ventricular repolarization: reality? Illusion? Significance? Circulation (1998) 1.32

MRI of hypertrophic cardiomyopathy: part I, MRI appearances. AJR Am J Roentgenol (2007) 1.26

QT dispersion and components of the QT interval in ischaemia and infarction. Br Heart J (1995) 1.24

Gap junction remodeling in hypertrophied left ventricles of aortic-banded rats: prevention by angiotensin II type 1 receptor blockade. J Mol Cell Cardiol (2001) 1.19

Relation of QT interval and QT dispersion to echocardiographic left ventricular hypertrophy and geometric pattern in hypertensive patients. The LIFE study. The Losartan Intervention For Endpoint Reduction. J Hypertens (2001) 1.17

Electrocardiographic localization of coronary artery narrowings: studies during myocardial ischemia and infarction in patients with one-vessel disease. Circulation (1982) 1.07

Long-term outcomes in hypertrophic cardiomyopathy caused by mutations in the cardiac troponin T gene. Circ Cardiovasc Genet (2011) 1.04

Spiral waves and reentry dynamics in an in vitro model of the healed infarct border zone. Circ Res (2009) 1.02

Dispersion of monophasic action potential durations and activation times during atrial pacing, ventricular pacing, and ventricular premature stimulation in canine ventricles. Cardiovasc Res (1983) 0.98

Electrocardiographic and coronary arteriographic correlations during acute myocardial infarction. Am J Cardiol (1984) 0.97

Influence of lead selection and population on automated measurement of QT dispersion. Circulation (1998) 0.93

QT-interval variability in hypertrophic cardiomyopathy patients with cardiac arrest. Int J Cardiol (1994) 0.92

QT dispersion in athletic left ventricular hypertrophy. Am Heart J (1999) 0.90

QT dispersion and risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy. Am J Cardiol (1998) 0.89

Dispersions of repolarization and ventricular arrhythmogenesis: lessons from animal models. Prog Biophys Mol Biol (2008) 0.88

Sudden death in hypertrophic cardiomyopathy. J Cardiovasc Transl Res (2009) 0.87

Dynamics of ventricular repolarization in patients with dilated cardiomyopathy versus healthy subjects. Ann Noninvasive Electrocardiol (2005) 0.86

Associations between fibrocytes and postcontrast myocardial T1 times in hypertrophic cardiomyopathy. J Am Heart Assoc (2013) 0.85

Ion channel remodeling in cardiac hypertrophy is prevented by blood pressure reduction without affecting heart weight increase in rats with abdominal aortic banding. J Cardiovasc Pharmacol (2002) 0.82

Electrophysiological characteristics of septal hypertrophy in patients with hypertrophic obstructive cardiomyopathy and moderate to severe symptoms. Circulation (2005) 0.79

Ventricular hypertrophy amplifies transmural dispersion of repolarization by preferentially increasing the late sodium current in endocardium. J Electrocardiol (2014) 0.78

QT dispersion and left ventricular morphology in patients with hypertrophic cardiomyopathy. Heart (2003) 0.77